- letzte 200 News
- Archiv
| Zeit | Aktuelle Nachrichten | Rating | Leser | ||
|---|---|---|---|---|---|
| 21.08. | NFON - H125 - a reminder that patience is required | 331 | Investors viewing NFON purely as a growth story might well be disappointed in its modest Q225 top-line growth, but they would be missing other factors. NFON is still in the final stages of a multi-year... ► Artikel lesen | ||
| 21.08. | Gresham House Energy Storage Fund - Debt refinancing unlocks growth potential | 208 | On 18 August 2025, Gresham House Energy Storage Fund (GRID) announced the signing of a new debt facility to refinance existing facilities. This reduces the fund's cost of debt and releases capital for... ► Artikel lesen | ||
| 21.08. | Mendus - Clinical activities on track | 240 | Mendus has reported its Q225 results. During the period, it made continued progress on the lead programme (vididencel in acute myeloid leukaemia, AML), which remains on track to be pivotal-stage ready... ► Artikel lesen | ||
| 19.08. | Nanoco Group - Encouraging commercial progress continues | 291 | Nanoco's trading update indicates that the business is making encouraging commercial progress since Dmitry Shashkov took over as CEO in October 2024. If all goes to plan, this should result in further... ► Artikel lesen | ||
| 19.08. | JDC Group - Higher estimates after 60% FMK acquisition | 441 | After the announcement that it has acquired 60% of lead-generating specialist FMK Group (FMK), JDC reported Q2 results last week. Management reiterated the new FY25 and FY26 guidance that was provided... ► Artikel lesen | ||
| 19.08. | Global Fashion Group - Delivered best Q2 profit since FY21 | 486 | Global Fashion Group's (GFG's) H125 results confirm continued growth in its two largest regions, Australia New Zealand (ANZ) and Latin America (LatAm) as they benefit from their prior repositioning... ► Artikel lesen | ||
| 19.08. | Immix Biopharma - Fleshing out the CAR-T strategy | 258 | Immix has published its Q225 results, reflecting a productive period for NXC-201. The US-based NEXICART-2 trial in relapsed/refractory amyloid light chain amyloidosis (r/r ALA) reported an encouraging... ► Artikel lesen | ||
| 15.08. | Herantis Pharma - Last patient visit completed for Phase Ib | 253 | Herantis Pharma has announced that patient visits have been completed for the final cohort from its Phase Ib trial evaluating lead candidate HER-096 in Parkinson's disease (PD). The primary objective... ► Artikel lesen | ||
| 15.08. | PVA TePla - Higher order momentum, guidance tweaked | 570 | In PVA TePla's (PVA's) Q225 results, higher opex, as expected, resulted in lower profits compared to Q224. However, order momentum appears to have gained traction, with an increase in order intake of... ► Artikel lesen | ||
| 15.08. | Basilea Pharmaceutica - New acquisition bolsters antibacterial franchise | 355 | Basilea Pharmaceutica has strengthened its antibacterial pipeline with the acquisition of global rights to the novel, orally administered, Phase-III ready asset, ceftibuten-ledaborbactam etzadroxil.... ► Artikel lesen | ||
| 14.08. | Pan American Silver - Another quarter of record cash flow generation | 484 | Pan American Silver's (PAAS's) Q2 production and AISC for both silver and gold were in line with quarterly guidance. Despite some sequential increase in costs and slightly lower sales, stronger commodity... ► Artikel lesen | ||
| 14.08. | Ocugen - Novel cell therapies for retinal diseases | 675 | Ocugen's modifier gene therapy (MGT) platform is designed to regulate gene expression to restore visual function across both genetically diverse inherited retinal diseases (IRDs) and retinal conditions... ► Artikel lesen | ||
| 13.08. | Deutsche Beteiligungs - Investments picked up in Q225, exits still muted | 423 | Deutsche Beteiligungs (DBAG) posted a 1.9% NAV total return (TR) in H125, with the positive impact of higher valuation multiples partly offset by a negative contribution from portfolio earnings growth... ► Artikel lesen | ||
| 13.08. | Sareum Holdings - New collaboration cements focus on CNS | 292 | Sareum has announced a strategic collaboration with Receptor.AI, a 'techbio' company harnessing generative AI to accelerate drug discovery across a range of targets, including TYK2. Sareum had previously... ► Artikel lesen | ||
| 13.08. | Theon International - Further strategic developments | 387 | Theon International has built a strong position in soldier night vision systems and is developing an Augmented Reality Modular Ecosystem of Devices (A.R.M.E.D.) product line supporting the next generation... ► Artikel lesen | ||
| 12.08. | VEON - Direct Digital drives earnings higher | 1.342 | VEON delivered a strong Q225, with revenue of $1,087m beating our estimate (3.4%) and underlying EBIT, (stripping out a $498m gain), of $322m, 13.2% ahead of our estimate. We have increased our adjusted... ► Artikel lesen | ||
| 12.08. | Newron Pharmaceuticals - ENIGMA-TRS 1 commences enrolment | 461 | Newron Pharmaceuticals has confirmed that enrolment has begun for its registrational ENIGMA-TRS Phase III programme for lead candidate evenamide. The first of two trials for the programme is ENIGMA-TRS... ► Artikel lesen | ||
| 12.08. | SIGA Technologies - A solid quarter for topline growth | 336 | Q225 was a strong quarter for SIGA, supported by material topline traction, with deliveries of $79m of oral and IV TPOXX to the US strategic national stockpile (SNS), fully servicing the order book... ► Artikel lesen | ||
| 12.08. | S&U - Q226 trading provides H2 support | 232 | S&U has issued a Q226 trading update confirming the growth trajectory of the business and providing support for H2 profit growth. The recent Supreme Court (SC) decision has given legal clarity to the... ► Artikel lesen | ||
| 11.08. | The Metals Company - Capital markets event adds positive colour | 372 | The Metals Company's (TMC's) application for an exploitation licence through the US legislative framework provides the potential to accelerate the group's plans and management now expects commercial... ► Artikel lesen | ||
| 11.08. | Target Healthcare REIT - Strong close to FY25 | 304 | Target Healthcare REIT's Q425 update shows indexed rent reviews continuing to drive increased earnings and property values, underpinning growing DPS. Q425 NAV total return was a strong 2.9%, taking... ► Artikel lesen | ||
| 11.08. | HELLENiQ ENERGY - Operationally excellent, offset by crude prices | 331 | HELLENiQ ENERGY delivered a resilient Q225 performance despite lower oil prices and the planned maintenance at the Elefsina refinery. Group sales fell 25.7% y-o-y to €2,433m, with reported EBITDA down... ► Artikel lesen | ||
| 11.08. | Theon International - Delivering the acquisition strategy | 376 | Theon has acquired German-based Kappa Group, a specialist optoelectronics business offering rugged and high-tech application for defence and niche applications. This will broaden Theon's technology... ► Artikel lesen | ||
| 08.08. | Wheaton Precious Metals - Salobo does it again | 527 | For the second quarter in succession, Wheaton Precious Metals (WPM) has announced record revenue, adjusted earnings and operational cash flows, posting adjusted net EPS that was 7.7% better than our... ► Artikel lesen | ||
| 08.08. | Filtronic - Targeting growth and diversification | 354 | Filtronic more than doubled revenue in FY25, helped by its strategic relationship with SpaceX. This dropped through to a 248% increase in adjusted EBITDA, a 342% increase in basic reported EPS and a... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .